GL1X · GenesisL1 explorer

Research workbench

Crystal structure of human methionine aminopeptidase-2 in complex with an inhibitor thiophene-2-sulfonic acid (4-fluoro-benzyl)-(4H-[1,2, 4]TRIAZOL-3-ylmethyl)-amide

Analyse Crystal structure of human methionine aminopeptidase-2 in complex with an… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6QEJ
Type
protein
Length
360 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Methionine aminopeptidase 2
EC
3.4.11.18
UniProt
P50579
Ligands
HZT, MN
Pockets
2 · best druggability 0.68

Structure

x-ray diffraction · 1 distinct chain · 31% helix, 26% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AMethionine aminopeptidase 2 (EC 3.4.11.18)protein36031% helix, 26% strandP50579

Ligands and binding sites

  • HZT · ~{N}-[(4-fluorophenyl)methyl]-~{N}-(1~{H}-1,2,4-triazol-5-ylmethyl)thiophene-2-sulfonamide · ligand · chains A
  • MN · Manganese (II) ion · metal · 2 copies · chains A
  • EDO · 1,2-ethanediol · additive · chains A
  • TBU · Tertiary-butyl alcohol · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12570.680.8437HZT
2520.530.8817empty

Compared structures

  • 6QEJ · CRYSTAL STRUCTURE OF HUMAN METHIONINE AMINOPEPTIDASE-2 IN COMPLEX WITH AN INHIBITOR… · the same entry in another collection · chain A against A, TM-score 1.00
  • P50579 · AlphaFold monomer V2.0 prediction for methionine aminopeptidase 2 (P50579) · a predicted model of the same protein · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.